Literature DB >> 24694491

Occurrence of IgG4-related hypophysitis lacking IgG4-bearing plasma cell infiltration during steroid therapy.

Yohsuke Ohkubo1, Takashi Sekido, Keiko Takeshige, Hiroaki Ishi, Masahiro Takei, Shin-ichi Nishio, Masanori Yamazaki, Mitsuhisa Komatsu, Shigeyuki Kawa, Satoru Suzuki.   

Abstract

Eight years after an episode of multiple IgG4-related disease, a pituitary mass with panhypopituitarism and a visual disturbance developed in a 70-year-old man under low-dose steroid therapy. A pituitary biopsy revealed findings of lymphocytic hypophysitis with the absence of IgG4-positive plasma cell infiltration. The serum IgG4 level was unremarkable. Although performing a pituitary biopsy and measuring the serum IgG4 level is crucial for making a diagnosis of IgG4-related hypophysitis, it is occasionally difficult to diagnose the disease in patients treated with steroid therapy, as observed in the present case. Based on a review of the diagnosis, conducting a careful assessment is required, especially in men and elderly patients thought to have solitary hypophysitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24694491     DOI: 10.2169/internalmedicine.53.0714

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

Review 1.  Critical review of IgG4-related hypophysitis.

Authors:  Junpei Shikuma; Kenshi Kan; Rokuro Ito; Kazuo Hara; Hiroyuki Sakai; Takashi Miwa; Akira Kanazawa; Masato Odawara
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 2.  IgG4-related hypophysitis.

Authors:  Alireza Amirbaigloo; Fatemeh Esfahanian; Marjan Mouodi; Nasser Rakhshani; Mehdi Zeinalizadeh
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

3.  [Clinical characteristics of central nervous system involvement in IgG4 related diseases].

Authors:  G Y Meng; Y X Zhang; Y X Zhang; Y Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

4.  Histologically confirmed isolated IgG4-related hypophysitis: two case reports in young women.

Authors:  Gabriela Alejandra Sosa; Soledad Bell; Silvia Beatriz Christiansen; Marcelo Pietrani; Mariela Glerean; Monica Loto; Soledad Lovazzano; Antonio Carrizo; Pablo Ajler; Patricia Fainstein Day
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-09-01

5.  Clinical course of IgG4-related hypophysitis presenting with focal seizure and relapsing lymphocytic hypophysitis.

Authors:  Kanchana Ngaosuwan; Therdkiat Trongwongsa; Shanop Shuangshoti
Journal:  BMC Endocr Disord       Date:  2015-10-29       Impact factor: 2.763

Review 6.  Hypophysitis: Evaluation and Management.

Authors:  Alexander Faje
Journal:  Clin Diabetes Endocrinol       Date:  2016-09-06

Review 7.  Overlap of Post-obstructive Diuresis and Unmasked Diabetes Insipidus in a Case of IgG4-related Retroperitoneal Fibrosis and Tuberoinfundibular Hypophysitis: A Case Report and Review of the Literature.

Authors:  Midori Sasaki Yatabe; Kimio Watanabe; Yoshimitsu Hayashi; Junichi Yatabe; Satoshi Morimoto; Atsuhiro Ichihara; Masaaki Nakayama; Tsuyoshi Watanabe
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

Review 8.  Clinical Characteristics of 76 Patients with IgG4-Related Hypophysitis: A Systematic Literature Review.

Authors:  Yujuan Li; Hua Gao; Zhen Li; Xinxin Zhang; Yizhi Ding; Fengao Li
Journal:  Int J Endocrinol       Date:  2019-12-18       Impact factor: 3.257

Review 9.  Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation: A case report and literature review.

Authors:  Wei-Jun Gu; Qian Zhang; Jian Zhu; Jie Li; Shi-Hui Wei; Yi-Ming Mu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

10.  Hypophyseal Involvement in Immunoglobulin G4-Related Disease: A Retrospective Study from a Single Tertiary Center.

Authors:  Yang Liu; Linjie Wang; Wen Zhang; Hui Pan; Hongbo Yang; Kan Deng; Lin Lu; Yong Yao; Shi Chen; Xiaofeng Chai; Feng Feng; Hui You; Zimeng Jin; Huijuan Zhu
Journal:  Int J Endocrinol       Date:  2018-03-20       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.